share_log

Neurizon Therapeutics Ltd: NUZ-001 Reduces Aggregation of Key ALS Disease Target

ASX ·  Nov 15, 2024 06:50
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more